SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bradpalm1 who wrote (3638)4/29/1998 2:05:00 PM
From: LoLoLoLita  Read Replies (1) of 7041
 
>>What's your explanation for the very high dropout rate in
>>Vasomax' Phase III trials?

Ohmigod, this is worse than the VVUS thread! Less science, and much more name-calling and what appears to be a plethora libelous innuendo.

Bradpalm,

Please tell us everything you know, and how you came to know it, about the Vasomax Phase III trials.

Dropout rate, efficacy, everything. Please tell us everything.

However, if this data is not "material public" or prohibited from disclosure by law or contract, then I believe it is inappropriate for you to discuss it here in any way, including the indirect manner you have used above.

Thanks in advance.

David
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext